STERIS plc (STE) To Go Ex-Dividend on June 8th

STERIS plc (NYSE:STE) announced a quarterly dividend on Tuesday, May 5th. Shareholders of record on Monday, June 8th will be given a dividend of 0.63 per share by the medical equipment provider on Friday, June 26th. This represents a c) annualized dividend and a yield of 1.2%. The ex-dividend date of this dividend is Monday, June 8th.

STERIS has raised its dividend payment by an average of 0.1%per year over the last three years and has increased its dividend every year for the last 20 years. STERIS has a dividend payout ratio of 22.9% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect STERIS to earn $12.04 per share next year, which means the company should continue to be able to cover its $2.52 annual dividend with an expected future payout ratio of 20.9%.

STERIS Trading Down 0.1%

NYSE:STE opened at $212.13 on Friday. The company has a debt-to-equity ratio of 0.25, a current ratio of 2.09 and a quick ratio of 1.54. The firm has a 50-day moving average of $217.24 and a 200-day moving average of $239.09. The company has a market cap of $20.70 billion, a PE ratio of 26.75 and a beta of 0.93. STERIS has a one year low of $195.14 and a one year high of $269.44.

STERIS (NYSE:STE) last posted its earnings results on Monday, May 11th. The medical equipment provider reported $2.83 EPS for the quarter, missing the consensus estimate of $2.86 by ($0.03). The business had revenue of $1.59 billion for the quarter, compared to the consensus estimate of $1.59 billion. STERIS had a return on equity of 14.15% and a net margin of 13.18%.The company’s revenue was up 6.7% on a year-over-year basis. During the same period in the previous year, the firm earned $2.74 earnings per share. STERIS has set its FY 2027 guidance at 11.100-11.300 EPS. As a group, equities research analysts expect that STERIS will post 11.18 EPS for the current fiscal year.

About STERIS

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.